On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

The approval of the Columvi combo, the first bispecific antibody regimen for DLBCL in Europe, follows a conditional marketing ...

Roche’s bispecific antibody, Columvi receives European approval for diffuse large B-cell lymphoma after initial therapy: Basel Tuesday, April 15, 2025, 10:00 Hrs [IST] Roche ann ...

BASEL, Switzerland I April 14, 2025 I Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Columvi® (glofitamab) in ...

As per Vantage Market Research, the Global Plasma Therapy Market has steadily grown over the years due to its potential to ...

Thank you. We are both truly honoured to step into these leadership roles and continue the great work initiated by Nico, ...

Transplantation of allogeneic hematopoietic stem cells (HSCs) is the only reported cure of HIV-1. Here, authors describe an autologous HSC transplant therapy with cells engineered for multilayered ...

Osteochondral autologous transplantation may be an effective treatment option for adolescent athletes with capitellar osteochondritis dissecans, according to results presented here.“This study has ...

Discover the latest findings on transplantation outcomes in Myelodysplastic Syndrome and Acute Myeloid Leukaemia from EBMT ...

The partners will use Cellino's autonomous biomanufacturing tech to produce high-quality autologous iPSCs for Karis' cardiovascular therapy.

The global regenerative medicine market is poised for exponential growth over the coming decade. Valued at approximately USD 9,802.5 million in 2025, the market is projected to reach a staggering USD ...

Explore the advancements in stem cell therapy for neurodegenerative diseases. Discover market size, trends, and growth projections for 2035 with a focus on treatment innovations.